12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Lexicon completes rights offering

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), The Woodlands, Texas
Business: Gastrointestinal, Autoimmune, Functional genomics
Date completed: 12/23/11
Type: Rights offering
Raised: $161 million...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >